The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $47.83

Today's change-0.24 -0.51%
Updated July 26 12:36 PM EDT. Delayed by at least 15 minutes.
 

Sanofi SA

NYSE: SNY
Last

(U.S.) $47.83

Today's change-0.24 -0.51%
Updated July 26 12:36 PM EDT. Delayed by at least 15 minutes.

Sanofi SA crosses below 20-day moving average

Sanofi SA is lower today, dropping (U.S.)$0.24 or 0.51% to (U.S.)$47.83 and crossing below its 20-day moving average. Over the last five days, shares have gained 2.17% and are currently 4.80% off of the 52-week high. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $48.10
  • Previous close(U.S.) $48.07
  • High(U.S.) $48.11
  • Low(U.S.) $47.76
  • Bid / Ask(U.S.) $47.82 / (U.S.) $47.83
  • YTD % change+18.26%
  • Volume344,871
  • Average volume (10-day)2,095,600
  • Average volume (1-month)1,648,474
  • Average volume (3-month)1,769,734
  • 52-week range(U.S.) $36.81 to (U.S.) $50.24
  • Beta0.88
  • Trailing P/E22.59×
  • P/E 1 year forward15.04×
  • Forward PEG1.53×
  • Indicated annual dividend(U.S.) $1.64
  • Dividend yield3.43%
  • Trailing EPS(U.S.) $2.12
Updated July 26 12:36 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+13.27%

Based on its net profit margin of 13.27%, Sanofi SA is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.14%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue8,89718,4729,29516,236
Total other revenue--------
Total revenue8,89718,4729,29516,236
Gross profit6,11212,7406,51911,266
Total cost of revenue2,7855,7322,7764,970
Total operating expense7,19615,0036,90413,658
Selling / general / administrative2,4784,8772,2744,609
Research & development1,3092,6581,2212,514
Depreciation / amortization503815403877
Interest expense (income), net operating--------
Unusual expense (income)11965684691
Other operating expenses, total2265146-3
Operating income1,7013,4692,3912,578
Interest income (expense), net non-operating---170---190
Gain (loss) on sale of assets--------
Other--------
Income before tax1,6383,2792,1472,399
Income after tax1,3022,4501,6871,902
Income tax, total336829460497
Net income5,7012,4641,6742,245
Total adjustments to net income--------
Net income before extra. items1,2742,4361,6641,959
Minority interest-34-50-29-41
Equity in affiliates636698
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,2742,4361,6641,959
Inc. avail. to common incl. extra. items5,7012,4641,6742,245
Diluted net income5,7012,4641,6742,245
Dilution adjustment--------
Diluted weighted average shares1,2621,2951,2891,297
Diluted EPS excluding extraordinary itemsvalue per share1.011.881.291.51
Dividends per sharevalue per share0.002.960.000.00
Diluted normalized EPSvalue per share1.082.261.341.93